Clinical trial
Effects of Type II Diabetes on Cognitive Functions in Middle-aged Patients
NCT05919927 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Type II Diabetes on Cognitive Functions in Middle-aged Patients
- Lead sponsor
- Tampere University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 7, 2018
- Completion date
- December 30, 2024
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive impairment, diabetes mellitus, type 2, hyperglycemia, hypoglycemia, mood